Literature DB >> 23991964

MicroRNA-16 inhibits bladder cancer proliferation by targeting Cyclin D1.

Qi-Quan Jiang1, Bin Liu, Tao Yuan.   

Abstract

MicroRNA-16 (miR-16) has been demonstrated to regulate proliferation and apoptosis in many types of cancers, but its biological function in bladder cancer remains unknown. Here, we found expression of miR-16 to be downregulated in bladder cancer in comparison with the adjacent normal tissues. Enforced expression of miR- 16 was able to inhibit cell proliferation in TCHu-1 cells, in line with results for miR-16 antisense oligonucleotides (antisense miR-16). At the molecular level, our results further revealed that cyclin D1 expression was negatively regulated by miR-16. Therefore, the data reported here demonstrate that miR-16 is an important regulator in bladder cancer, which will contribute to better understanding of important mis-regulated miRNAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23991964     DOI: 10.7314/apjcp.2013.14.7.4127

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  31 in total

1.  Matrine inhibits the growth and induces apoptosis of osteosarcoma cells in vitro by inactivating the Akt pathway.

Authors:  Gong-Ping Xu; Wei Zhao; Jin-Peng Zhuang; Jia-Ning Zu; Duan-Yang Wang; Fei Han; Zhi-Peng Zhang; Jing-Long Yan
Journal:  Tumour Biol       Date:  2014-11-05

2.  Regulation of growth of human bladder cancer by miR-192.

Authors:  Yongchao Jin; Jiasun Lu; Jiling Wen; Yinzhou Shen; Xiaofei Wen
Journal:  Tumour Biol       Date:  2015-01-09

3.  MiR-592 inhibited cell proliferation of human colorectal cancer cells by suppressing of CCND3 expression.

Authors:  Zhehui Liu; Ruiqin Wu; Guanzeng Li; Peng Sun; Qinghua Xu; Zhimin Liu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.

Authors:  Ritu Shekhar; Priyanka Priyanka; Praveen Kumar; Tanushree Ghosh; Md Muntaz Khan; Perumal Nagarajan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

5.  MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.

Authors:  L Venturutti; R I Cordo Russo; M A Rivas; M F Mercogliano; F Izzo; R H Oakley; M G Pereyra; M De Martino; C J Proietti; P Yankilevich; J C Roa; P Guzmán; E Cortese; D H Allemand; T H Huang; E H Charreau; J A Cidlowski; R Schillaci; P V Elizalde
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

6.  Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.

Authors:  Yudi Zhu; Shaosi Liang; Huafeng Pan; Zhongliang Cheng; Xin Rui
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

7.  Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival.

Authors:  Bing-Xin Li; Qi Yu; Ze-Liang Shi; Ping Li; Shen Fu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 8.  Interrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAs.

Authors:  Junli Xue; Victoria K Xie; Peipei Wang; Jiujie Cui; Yong Gao; Zhimin Lu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 9.  Role of miR-15/16 in CLL.

Authors:  Y Pekarsky; C M Croce
Journal:  Cell Death Differ       Date:  2014-06-27       Impact factor: 15.828

Review 10.  BCL2 and miR-15/16: from gene discovery to treatment.

Authors:  Yuri Pekarsky; Veronica Balatti; Carlo M Croce
Journal:  Cell Death Differ       Date:  2017-10-06       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.